NYSE:PFE
Pfizer
- Stock
Share Trends
Recent Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
Boshoff Christoffel Executive Vice President Common Stock | 2024-03-01 | 7.36K 4.95% |
Dolsten Mikael President R&D Common Stock | 2024-02-29 | -21.44K −6.25% |
Damico Jennifer B. SVP & Controller Common Stock | 2024-02-28 | 5.11K 61.00% |
De Germay Alexandre Executive Vice President Common Stock | 2024-02-28 | 74.38K 100% |
Sahni Payal Executive Vice President Common Stock | 2024-02-27 | 1.31K 5.67% |
Largest Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
Read Ian C Chairman & CEO Common Stock | 2018-11-06 | 1.10M 166.51% |
Read Ian C Executive Chairman Common Stock | 2019-02-26 | -193.17K −10.85% |
Dolsten Mikael President R&D Common Stock | 2021-11-15 | 139.88K 99.95% |
Bourla Albert Chairman & CEO Common Stock | 2020-11-10 | -132.51K −62.87% |
Dolsten Mikael President R&D Common Stock | 2019-02-01 | 125.97K 53.36% |
Transaction Log
| Filing Date | Transaction Date | Reporter | Title | Post Shares | Quantity | T | Stock Class | USD |
|---|---|---|---|---|---|---|---|---|
2024-03-01 | 2024-02-28 | Boshoff Christoffel | Executive Vice President | 160.16K | 11.51K | A | Common Stock | 0 |
2024-03-01 | 2024-02-28 | Boshoff Christoffel | Executive Vice President | 156.01K | 4.15K | F | Common Stock | -112.22K |
2024-02-29 | 2024-02-28 | Dolsten Mikael | President R&D | 321.73K | 21.44K | F | Common Stock | -579.66K |
2024-02-28 | 2024-02-27 | De Germay Alexandre | Executive Vice President | 74.38K | 74.38K | A | Common Stock | 0 |
2024-02-28 | 2024-02-27 | Damico Jennifer B. | SVP & Controller | 13.49K | 5.11K | A | Common Stock | 0 |
2024-02-27 | 2024-02-23 | Dolsten Mikael | President R&D | 343.17K | 24.82K | F | Common Stock | -689.06K |
2024-02-27 | 2024-02-23 | Damico Jennifer B. | SVP & Controller | 18.78K | 451 | F | Common Stock | -12.52K |
2024-02-27 | 2024-02-23 | Mcdermott Michael | Executive Vice President | 95.41K | 12.41K | M | Common Stock | 339.34K |
2024-02-27 | 2024-02-25 | Boshoff Christoffel | Executive Vice President | 153.44K | 1.40K | F | Common Stock | -38.95K |
2024-02-27 | 2024-02-23 | Lankler Douglas M | Executive Vice President | 230.92K | 95.75K | M | Common Stock | 2.62M |
2024-02-27 | 2024-02-23 | Johnson Rady A | Executive Vice President | 97.15K | 23.79K | F | Common Stock | -651.08K |
2024-02-27 | 2024-02-23 | Susman Sally | Executive Vice President | 213.20K | 4.95K | F | Common Stock | -137.36K |
2024-02-27 | 2024-02-23 | Bourla Albert | Chairman & CEO | 439.75K | 127.67K | M | Common Stock | 3.49M |
2024-02-27 | 2024-02-24 | Boshoff Christoffel | Executive Vice President | 139.39K | 300 | F | Common Stock | -8.33K |
2024-02-27 | 2024-02-23 | Lankler Douglas M | Executive Vice President | 224.30K | 6.62K | F | Common Stock | -183.72K |
2024-02-27 | 2024-02-23 | Damico Jennifer B. | SVP & Controller | 19.23K | 9.75K | M | Common Stock | 266.62K |
2024-02-27 | 2024-02-23 | Mcdermott Michael | Executive Vice President | 94.55K | 859 | F | Common Stock | -23.85K |
2024-02-27 | 2024-02-23 | Lankler Douglas M | Executive Vice President | 146.92K | 77.38K | F | Common Stock | -2.12M |
2024-02-27 | 2024-02-23 | Boshoff Christoffel | Executive Vice President | 139.69K | 7.88K | F | Common Stock | -215.70K |
2024-02-27 | 2024-02-26 | Mcdermott Michael | Executive Vice President | 75.46K | 6.06K | F | Common Stock | -164.79K |
2024-02-27 | 2024-02-23 | Johnson Rady A | Executive Vice President | 120.94K | 2.13K | F | Common Stock | -59.18K |
2024-02-27 | 2024-02-23 | Boshoff Christoffel | Executive Vice President | 148.70K | 9.75K | M | Common Stock | 266.62K |
2024-02-27 | 2024-02-23 | Mcdermott Michael | Executive Vice President | 84.52K | 10.03K | F | Common Stock | -274.55K |
2024-02-27 | 2024-02-23 | Bourla Albert | Chairman & CEO | 327.74K | 103.18K | F | Common Stock | -2.82M |
2024-02-27 | 2024-02-24 | Damico Jennifer B. | SVP & Controller | 9.77K | 354 | F | Common Stock | -9.83K |
2024-02-27 | 2024-02-23 | Sahni Payal | Executive Vice President | 33.70K | 905 | F | Common Stock | -25.12K |
2024-02-27 | 2024-02-25 | Mcdermott Michael | Executive Vice President | 81.53K | 2.99K | F | Common Stock | -83.06K |
2024-02-27 | 2024-02-23 | Susman Sally | Executive Vice President | 161.61K | 51.59K | F | Common Stock | -1.41M |
2024-02-27 | 2024-02-23 | Bourla Albert | Chairman & CEO | 430.92K | 8.83K | F | Common Stock | -245.15K |
2024-02-27 | 2024-02-25 | Boshoff Christoffel | Executive Vice President | 154.84K | 15.46K | A | Common Stock | 0 |
2024-02-27 | 2024-02-25 | Boshoff Christoffel | Executive Vice President | 148.65K | 4.79K | F | Common Stock | -133.08K |
2024-02-27 | 2024-02-23 | Sahni Payal | Executive Vice President | 24.39K | 9.31K | F | Common Stock | -254.92K |
2024-02-27 | 2024-02-25 | Damico Jennifer B. | SVP & Controller | 8.38K | 1.39K | F | Common Stock | -38.48K |
2024-02-27 | 2024-02-23 | Sahni Payal | Executive Vice President | 34.60K | 11.53K | M | Common Stock | 315.15K |
2024-02-27 | 2024-02-23 | Boshoff Christoffel | Executive Vice President | 147.57K | 675 | F | Common Stock | -18.74K |
2024-02-27 | 2024-02-23 | Boshoff Christoffel | Executive Vice President | 148.25K | 458 | F | Common Stock | -12.71K |
2024-02-27 | 2024-02-23 | Susman Sally | Executive Vice President | 218.15K | 63.84K | M | Common Stock | 1.75M |
2024-02-27 | 2024-02-23 | Damico Jennifer B. | SVP & Controller | 10.12K | 7.88K | F | Common Stock | -215.70K |
2024-02-27 | 2024-02-23 | Damico Jennifer B. | SVP & Controller | 18.00K | 774 | F | Common Stock | -21.49K |
2024-02-27 | 2024-02-23 | Johnson Rady A | Executive Vice President | 123.07K | 29.44K | M | Common Stock | 804.78K |
2023-12-19 | 2023-12-15 | Gottlieb Scott | Director | 9K | 3K | P | Common Stock | 79.40K |
2023-06-01 | 2023-05-31 | Denton David M | Chief Financial Officer & EVP | 48.22K | 16.22K | F | Common Stock | -616.80K |
2023-05-09 | 2023-05-05 | Gottlieb Scott | Director | 5K | 1K | P | Common Stock | 38.42K |
2023-05-09 | 2023-05-08 | Gottlieb Scott | Director | 6K | 1K | P | Common Stock | 38.58K |
2023-03-17 | 2023-03-15 | Damico Jennifer B. | SVP & Controller | 9.00K | 9.91K | S | Common Stock | -396.68K |
2023-03-17 | 2023-02-24 | Damico Jennifer B. | SVP & Controller | 16.38K | 360 | F | Common Stock | -15.03K |
2023-02-28 | 2023-02-25 | Susman Sally | Executive Vice President | 154.31K | 32.45K | F | Common Stock | -1.41M |
2023-02-28 | 2023-02-25 | Johnson Rady A | Executive Vice President | 93.64K | 14.97K | F | Common Stock | -650.12K |
2023-02-28 | 2023-02-25 | Johnson Rady A | Executive Vice President | 116.47K | 33.65K | M | Common Stock | 770.34K |
2023-02-28 | 2023-02-25 | Susman Sally | Executive Vice President | 209.18K | 72.98K | M | Common Stock | 1.67M |
2023-02-28 | 2023-02-25 | Susman Sally | Executive Vice President | 186.77K | 22.41K | F | Common Stock | -935.74K |
2023-02-28 | 2023-02-27 | Damico Jennifer B. | SVP & Controller | 19.27K | 1.43K | F | Common Stock | -58.19K |
2023-02-28 | 2023-02-25 | Hwang Angela | President, Global Biopharma | 29.78K | 9.02K | F | Common Stock | -391.61K |
2023-02-28 | 2023-02-25 | Damico Jennifer B. | SVP & Controller | 25.66K | 2.23K | F | Common Stock | -93.23K |
2023-02-28 | 2023-02-25 | Johnson Rady A | Executive Vice President | 108.60K | 7.87K | F | Common Stock | -328.57K |
2023-02-28 | 2023-02-25 | Damico Jennifer B. | SVP & Controller | 27.89K | 11.15K | M | Common Stock | 255.22K |
2023-02-28 | 2023-02-25 | Mcdermott Michael | Executive Vice President | 90.26K | 2.84K | F | Common Stock | -118.53K |
2023-02-28 | 2023-02-25 | Mcdermott Michael | Executive Vice President | 83.95K | 6.30K | F | Common Stock | -273.89K |
2023-02-28 | 2023-02-27 | Mcdermott Michael | Executive Vice President | 80.87K | 3.08K | F | Common Stock | -125.64K |
2023-02-28 | 2023-02-25 | Hwang Angela | President, Global Biopharma | 44.54K | 20.27K | M | Common Stock | 464.05K |
2023-02-28 | 2023-02-25 | Mcdermott Michael | Executive Vice President | 93.10K | 14.18K | M | Common Stock | 324.53K |
2023-02-28 | 2023-02-25 | Sahni Payal | Executive Vice President | 24.37K | 3.97K | F | Common Stock | -172.33K |
2023-02-28 | 2023-02-27 | Sahni Payal | Executive Vice President | 23.08K | 1.30K | F | Common Stock | -52.89K |
2023-02-28 | 2023-02-25 | Sahni Payal | Executive Vice President | 28.34K | 1.79K | F | Common Stock | -74.57K |
2023-02-28 | 2023-02-25 | Sahni Payal | Executive Vice President | 30.13K | 8.92K | M | Common Stock | 204.20K |
2023-02-28 | 2023-02-25 | Damico Jennifer B. | SVP & Controller | 20.70K | 4.96K | F | Common Stock | -215.38K |
2023-02-28 | 2023-02-25 | Hwang Angela | President, Global Biopharma | 38.79K | 5.75K | F | Common Stock | -239.98K |
2023-02-24 | 2023-02-22 | Lankler Douglas M | Executive Vice President | 161.53K | 19.88K | F | Common Stock | -842.43K |
2023-02-24 | 2023-02-22 | Johnson Rady A | Executive Vice President | 102.03K | 4.53K | F | Common Stock | -191.81K |
2023-02-24 | 2023-02-22 | Johnson Rady A | Executive Vice President | 82.82K | 19.21K | F | Common Stock | -839.52K |
2023-02-24 | 2023-02-22 | Johnson Rady A | Executive Vice President | 106.56K | 31.56K | M | Common Stock | 952.10K |
2023-02-24 | 2023-02-22 | Susman Sally | Executive Vice President | 195.49K | 76.04K | M | Common Stock | 2.29M |
2023-02-24 | 2023-02-22 | Susman Sally | Executive Vice President | 182.49K | 13.01K | F | Common Stock | -551.24K |
2023-02-24 | 2023-02-22 | Susman Sally | Executive Vice President | 136.19K | 46.29K | F | Common Stock | -2.02M |
2023-02-24 | 2023-02-22 | Hwang Angela | President, Global Biopharmaceu | 24.27K | 34.72K | F | Common Stock | -1.52M |
2023-02-24 | 2023-02-22 | Hwang Angela | President, Global Biopharmaceu | 67.03K | 57.03K | M | Common Stock | 1.72M |
2023-02-24 | 2023-02-23 | Damico Jennifer B. | SVP & Controller | 16.74K | 3.10K | A | Common Stock | 0 |
2023-02-24 | 2023-02-22 | Mcdermott Michael | Executive Vice President | 78.92K | 8.10K | F | Common Stock | -354.01K |
2023-02-24 | 2023-02-22 | Sahni Payal | Executive Vice President | 32.67K | 15.21K | M | Common Stock | 458.86K |
2023-02-24 | 2023-02-22 | Damico Jennifer B. | SVP & Controller | 20.00K | 1.58K | F | Common Stock | -66.92K |
2023-02-24 | 2023-02-22 | Damico Jennifer B. | SVP & Controller | 21.58K | 10.46K | M | Common Stock | 315.46K |
2023-02-24 | 2023-02-22 | Mcdermott Michael | Executive Vice President | 87.02K | 1.94K | F | Common Stock | -82.01K |
2023-02-24 | 2023-02-22 | Dolsten Mikael | President R&D | 391.22K | 32.59K | F | Common Stock | -1.38M |
2023-02-24 | 2023-02-22 | Mcdermott Michael | Executive Vice President | 88.96K | 13.31K | M | Common Stock | 401.47K |
2023-02-24 | 2023-02-22 | Damico Jennifer B. | SVP & Controller | 13.64K | 6.37K | F | Common Stock | -278.15K |
2023-02-24 | 2023-02-22 | Hwang Angela | President, Global Biopharmaceu | 58.99K | 8.04K | F | Common Stock | -340.78K |
2023-02-24 | 2023-02-22 | Bourla Albert | Chairman & CEO | 352.48K | 61.99K | F | Common Stock | -2.63M |
2023-02-24 | 2023-02-22 | Sahni Payal | Executive Vice President | 21.21K | 9.26K | F | Common Stock | -404.62K |
2023-02-24 | 2023-02-22 | Sahni Payal | Executive Vice President | 30.46K | 2.21K | F | Common Stock | -93.49K |
2022-06-08 | 2022-06-07 | Damico Jennifer B. | SVP & Controller | 10.85K | 4.22K | S | Common Stock | -227.60K |
2022-06-01 | 2022-05-31 | Denton David M | Chief Financial Officer & EVP | 62.16K | 61.27K | A | Common Stock | 0 |
2022-05-17 | 2022-05-16 | Damico Jennifer B. | SVP & Controller | 15.06K | 4K | S | Common Stock | -202K |
2022-05-16 | 2022-05-13 | Sahni Payal | Executive Vice President | 17.37K | 1.41K | S | Common Stock | -70.17K |
2022-05-13 | 2022-05-12 | Lankler Douglas M | Executive Vice President | 78.80K | 38.27K | S | Common Stock | -1.89M |
2022-05-13 | 2022-05-12 | Carapezzi William R Jr | Executive Vice President | 38.15K | 32.91K | S | Common Stock | -1.65M |
2022-05-12 | 2022-05-11 | Dolsten Mikael | President R&D | 365.36K | 18.56K | S | Common Stock | -915.48K |
2022-05-12 | 2022-05-11 | Dolsten Mikael | President R&D | 383.92K | 7.88K | S | Common Stock | -388.52K |
2022-05-12 | 2022-05-11 | Dolsten Mikael | President R&D | 333.34K | 32.02K | S | Common Stock | -1.58M |
2022-05-12 | 2022-05-11 | Susman Sally | Executive Vice President | 119.45K | 5K | G | Common Stock | 0 |
2022-05-12 | 2022-05-11 | Dolsten Mikael | President R&D | 394.69K | 2.36K | S | Common Stock | -116.34K |